Smart patch lets gut surgery patients go home days earlier
NCT ID NCT07552805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wearable patch called MultiSense that tracks heart rate and other vital signs for five days after a patient leaves the hospital following major digestive surgery. The goal is to see if the patch allows high-risk patients to be discharged earlier while still catching complications early. About 490 adults will be randomly assigned to either the patch or standard follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens-Picardie
NOT_YET_RECRUITINGAmiens, 80000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Charles-Nicolle
NOT_YET_RECRUITINGRouen, Seine-Maritime, 76000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Besançon
NOT_YET_RECRUITINGBesançon, Doubs, 25000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nice
NOT_YET_RECRUITINGNice, Alpes-Maritimes, 06000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Cochin, AP-HP Centre
RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Yogurt as medicine? Butyrate-Rich formula tested for Cancer-Related constipation
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Can a walking routine alter cancer biomarkers? new trial investigates